Skip to content

Clinical trials

Phase 1/2 Lymphoma, Large-Cell, Anaplastic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large-Cell, Anaplastic Phase: Phase 1/2 Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20032
20051
20062
20073
20083
20094
20101
20113
20122
20133
20141
20151
20171
20182
20191
20203
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated8
Withdrawn3
Active, not recruiting3
Recruiting2
Unknown status2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center4
Fred Hutchinson Cancer Center3
National Cancer Institute (NCI)3
Bristol-Myers Squibb2
City of Hope Medical Center2
Columbia University2
Mayo Clinic2
Memorial Sloan Kettering Cancer Center2
Northwestern University2
University of Nebraska2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large-Cell, Anaplastic43
Immunoblastic Lymphadenopathy26
Hodgkin Disease22
Lymphoma, Large B-Cell, Diffuse22
Lymphoma20
Lymphoma, Non-Hodgkin19
Lymphoma, Follicular18
Lymphoma, Mantle-Cell18
Lymphoma, T-Cell, Cutaneous18
Mycosis Fungoides18

Trials

Showing 76 to 43 of 43. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.